These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33942339)
1. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein. Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339 [TBL] [Abstract][Full Text] [Related]
2. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene. Tso FY; West JT; Wood C J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362 [TBL] [Abstract][Full Text] [Related]
4. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus. Liang Z; Qin Z; Riker AI; Xi Y Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788 [TBL] [Abstract][Full Text] [Related]
6. Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells. Haddad CO; Kalt I; Shovman Y; Xia L; Schlesinger Y; Sarid R; Parnas O Virol J; 2021 Mar; 18(1):56. PubMed ID: 33731154 [TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin. Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433 [TBL] [Abstract][Full Text] [Related]
8. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells. Gruffaz M; Yuan H; Meng W; Liu H; Bae S; Kim JS; Lu C; Huang Y; Gao SJ mBio; 2019 May; 10(3):. PubMed ID: 31088931 [TBL] [Abstract][Full Text] [Related]
10. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
11. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells. Holmes DL; Vogt DT; Lagunoff M Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441 [TBL] [Abstract][Full Text] [Related]
12. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis. Sun Z; Jha HC; Robertson ES J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324 [TBL] [Abstract][Full Text] [Related]
14. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Qin Z; Dai L; Slomiany MG; Toole BP; Parsons C Cancer Res; 2010 May; 70(10):3884-9. PubMed ID: 20406987 [TBL] [Abstract][Full Text] [Related]
15. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency. Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521 [TBL] [Abstract][Full Text] [Related]
16. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance. Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680 [TBL] [Abstract][Full Text] [Related]
18. KSHV Genome Replication and Maintenance in Latency. Ueda K Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673 [TBL] [Abstract][Full Text] [Related]
19. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency. Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201 [TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]